Chemours Co. shares rose 0.8% after the chemical manufacturer reached an agreement with federal and state authorities to resolve enforcement claims related to releases of per- and polyfluoroalkyl substances (PFAS), often described as "forever chemicals." The settlement, valued at $450 million, settles alleged violations at four facilities located in West Virginia, North Carolina and New Jersey.
The settlement was negotiated with the U.S. Department of Justice, the Environmental Protection Agency and the West Virginia Department of Environmental Protection. Authorities had alleged that operations at some Chemours sites violated multiple environmental statutes, including the Clean Water Act, the Resource Conservation and Recovery Act, the Toxic Substances Control Act and the West Virginia Water Pollution Control Act.
Under the terms of the agreement, Chemours will pay a civil penalty of $22.5 million and implement a multi-year program budgeted at $90 million aimed at mitigating PFAS discharges. Separately, the company is expected to fund installation of PFAS pollution controls for surface water discharges and air emissions at its West Virginia plant, with those controls estimated to cost about $60 million.
A substantial portion of the settlement is dedicated to supplying clean drinking water to communities near Chemours facilities in West Virginia and New Jersey. The company will provide clean water for more than a decade, with that obligation estimated to cost approximately $280 million. The agreement also requires Chemours to evaluate and put in place additional controls to limit releases of PFAS and other toxic chemicals from its North Carolina facility.
The enforcement complaint asserted that three Chemours facilities discharged PFAS into the Ohio River, the Cape Fear River and the Delaware River in ways that violated Clean Water Act permits. According to the complaint, these alleged violations persisted for more than a decade at facilities that had previously been owned by DuPont. The settlement explicitly does not resolve any liability that DuPont may face related to forever chemicals.
As part of the consent decree, Chemours must complete 14 specified projects aimed at reducing PFAS concentrations in wastewater, stormwater and groundwater stemming from the West Virginia plant. Those programs are slated to run for 15 years. The agreement also allows Chemours to continue manufacturing PFAS for applications designated as critical for commercial and military use.
Key points
- Chemours agreed to a $450 million settlement with federal and state regulators to resolve PFAS enforcement claims at four facilities across three states.
- The settlement includes a $22.5 million civil penalty, a $90 million mitigation program, and roughly $60 million in pollution-control installations at the West Virginia plant.
- Chemours will provide treated drinking water to impacted communities in West Virginia and New Jersey for more than a decade, an obligation estimated at $280 million; the settlement also permits continued PFAS manufacturing for certain critical uses.
Risks and uncertainties
- Ongoing regulatory and remediation obligations - The consent decree establishes multi-year programs and projects spanning up to 15 years, which could influence Chemours' operational and capital planning.
- Outstanding third-party liability - The settlement does not address any liability that may be attributed to DuPont for past releases at sites previously owned by that company.
- Legal and compliance oversight - The agreement resolves current enforcement claims listed in the complaint, but the nature of the consent decree imposes long-term compliance requirements that will need sustained execution and oversight.
The settlement was described as the first comprehensive federal agreement to resolve enforcement claims against a manufacturer over pollution linked to PFAS. Beyond the monetary components, the consent decree outlines specific remediation and control projects designed to cut PFAS releases to surface water, stormwater and groundwater, and it defines community water-supply obligations for affected areas.
Investors reacted modestly to the resolution; shares of Chemours rose 0.8% on the day the agreement was announced. The company retains the ability to produce PFAS for designated critical commercial and military applications under the terms of the settlement.